Ameritas Investment Partners, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,880
-53.9%
9,8030.0%0.00%
Q2 2023$12,744
-26.1%
9,8030.0%0.00%
-100.0%
Q1 2023$17,253
-48.8%
9,8030.0%0.00%0.0%
Q4 2022$33,722
-29.7%
9,8030.0%0.00%
-50.0%
Q3 2022$48,000
+20.0%
9,8030.0%0.00%0.0%
Q2 2022$40,000
-29.8%
9,8030.0%0.00%0.0%
Q1 2022$57,000
-23.0%
9,8030.0%0.00%0.0%
Q4 2021$74,000
-15.9%
9,8030.0%0.00%
-33.3%
Q3 2021$88,000
-24.8%
9,8030.0%0.00%
-25.0%
Q2 2021$117,000
-4.9%
9,8030.0%0.00%
-20.0%
Q1 2021$123,000
-19.6%
9,8030.0%0.01%
-28.6%
Q4 2020$153,000
+64.5%
9,8030.0%0.01%
+75.0%
Q3 2020$93,000
+5.7%
9,8030.0%0.00%0.0%
Q2 2020$88,000
+41.9%
9,8030.0%0.00%0.0%
Q1 2020$62,000
-24.4%
9,8030.0%0.00%0.0%
Q4 2019$82,000
-7.9%
9,8030.0%0.00%0.0%
Q3 2019$89,000
-16.0%
9,8030.0%0.00%
-20.0%
Q2 2019$106,000
+34.2%
9,803
+18.6%
0.01%
+25.0%
Q1 2019$79,000
-16.8%
8,2650.0%0.00%
-20.0%
Q4 2018$95,000
-32.1%
8,2650.0%0.01%
-16.7%
Q3 2018$140,000
+19.7%
8,2650.0%0.01%0.0%
Q2 2018$117,000
-12.7%
8,265
+17.0%
0.01%0.0%
Q1 2018$134,000
+15.5%
7,0670.0%0.01%
+20.0%
Q4 2017$116,000
+52.6%
7,067
+22.8%
0.01%
+25.0%
Q3 2017$76,000
+49.0%
5,7560.0%0.00%
+100.0%
Q2 2017$51,000
+70.0%
5,7560.0%0.00%
+100.0%
Q1 2017$30,0005,7560.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders